Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain cell injection aims to tame Drug-Resistant seizures

NCT ID NCT07572812

First seen May 22, 2026 · Last updated May 23, 2026 · Updated 1 time

Summary

This early-stage trial tests a new treatment called UX-GIP001 for adults with drug-resistant epilepsy that starts in one side of the brain's temporal lobe. The treatment involves injecting special brain cells that may help calm overactive nerve signals. The study will enroll 12 people to check if the therapy is safe and if it can reduce seizure frequency.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Tiantan Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100070, China

    Contact

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, 450000, China

    Contact

  • West China School of Medicine and West China Hospital, Sichuan University

    Chengdu, Sichuan, 610041, China

    Contact

Conditions

Explore the condition pages connected to this study.